What is the long-term trend for Xtant Medical Holdings's unamortized debt issuance expense?

Over 3 years (2022 to 2025), Xtant Medical Holdings's unamortized debt issuance expense has grown at a 14.1% compound annual growth rate (CAGR), from $196K to $291K.

Xtant Medical Holdings XTNT Unamortized Debt Issuance Expense

Unamortized Debt Issuance Expense at other companies

UMH

UMH PropertiesUMH

-$5.74M-63.6%

Blackstone Secured Lending FundBXSL

$18.7M-8.8%

Pathfinder BancorpPBHC

$71.99M+5.5%

LGI HomesLGIH

$20.84M—

Tarsus Pharmaceuticals, Inc.TARS

$3.52M0.0%

LTC PropertiesLTC

$4.42M+263%

Other financials

Income statement

See full

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

See full

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation

See full

Market cap$59.05M-32.5%

Enterprise value$61.89M-41.5%

P/E32.3×—

P/S0.5×-0.2×

Profitability

See full

Gross margin62.3%+4.2pp

Operating margin4.8%+2.8pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

See full

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:UnamortizedDebtIssuanceExpense.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's unamortized debt issuance expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xtant Medical Holdings's unamortized debt issuance expense?: Xtant Medical Holdings (XTNT) reported unamortized debt issuance expense of $249K in Q1 2026.
How has Xtant Medical Holdings's unamortized debt issuance expense changed year-over-year?: Xtant Medical Holdings's unamortized debt issuance expense decreased by 37.1% year-over-year, from $396K to $249K.
What is the long-term trend for Xtant Medical Holdings's unamortized debt issuance expense?: Over 3 years (2022 to 2025), Xtant Medical Holdings's unamortized debt issuance expense has grown at a 14.1% compound annual growth rate (CAGR), from $196K to $291K.